Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Q2 Metals Intercepts 151 Metres of Continuous Spodumene Pegmatite at the Cisco Lithium Project in Quebec, Canada and Announces Option Payments on Cisco Project Properties
-
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch
-
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization
-
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
-
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
-
Parsons Corporation is Ready Now to Build America’s Brand New, State Of-The-Art Air Traffic Control System
-
Constellium Honored with Three Supplier Awards from Airbus
-
Sunrise Realty Trust Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025
-
Advanced Flower Capital Schedules Earnings Release and Conference Call for the Second Quarter Ending June 30, 2025
-
POET Signs Manufacturing Agreement with NationGate Solutions in Malaysia
-
New EU-Canada Partnership to bolster trade, competition and economic security while prioritizing clean energy and industry
-
Volta Finance Limited - Net Asset Value(s) as at 31 May 2025
-
BloFin futures performance rivals top exchanges across BTC, ETH, and leading altcoins
-
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
-
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
-
Array Technologies Announces Proposed Private Offering of $250 Million of New Convertible Senior Notes
-
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
-
Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities
-
Chris Pogue Joins Calian as President, Defence & Space, Powering Calian’s Next-Generation Defence and Space Capabilities
-
Local Author M.B. Mooney Writes Children’s Book to Raise Awareness About Crohn’s Disease
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Microchip Enhances TrustMANAGER Platform to Support CRA Compliance and Cybersecurity Regulations
-
Erdene Releases 2025 Shareholder Letter
-
Red White & Bloom Brands Announces New Date for Annual General Meeting
-
Pickle Robot Hires New VP of Engineering, Adding 50 New Engineers by September as Warehouse Robotics Demand Surges
-
Nuttee Bean Co. Launches Favalicious Fava Bean-Based Pasta Offering High Protein, Low Carb, and Classic Taste
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
StorageVault Completes the Purchase of 8 Assets for $71.9 Million
-
Rocky Shore Initiates Summer Program at Gold Anchor Project, Newfoundland
-
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addi
-
The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
-
Fogo de Chão Kicks Off Hot Brazilian Summer with the Launch of Sizzling New Off-Menu Cocktail and New Song Release
-
Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America
-
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
-
Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum
-
Pando and JBF Consulting Release 2025 Report on the State of AI in Logistics
-
Lantronix Named the 2025 Industrial IoT Company of the Year by Leading Market Research Firm CompassIntel
-
Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure
-
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
-
Addressing Surging Demand, Vetty Reports Strong Growth, Strategic Wins and Expanded Integrations in 1H 2025
-
Macerich Acquires Market-Dominant Crabtree Mall in Raleigh, NC for $290 million
-
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
-
TRANSDEV SECURES AGREEMENT TO CONTINUE OPERATIONS AT CITY OF PHOENIX WEST TRANSIT FACILITY
-
Tilray Medical Receives Italy’s First Authorization from the Ministry of Health to Distribute Medical Cannabis Flower for Therapeutic Use
-
Brera Holdings Announces Reverse Share Split to Regain Compliance with Nasdaq’s Minimum Bid Price Rule
-
Fogo de Chão Kicks Off Hot Brazilian Summer with the Launch of Sizzling New Off-Menu Cocktail and New Song Release
-
The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
-
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
-
Plug Executive Leadership to Participate in Investor Conferences in New York and London
-
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
